Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032
Overview
The Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market is expected to reach a 70.34 USD Million by 2032 and is projected to grow at a CAGR of 38.80% from 2025 to 2032.
Revenue, 2024 (USD Million)
12.33
Forecast, 2032 (USD Million)
70.34
CAGR, 2024 - 2032
38.80%
Report Coverage
Australia
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market 2018-2032 USD Million
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 12.33 USD Million
- Projected Market Size (2032): 70.34 USD Million
- CAGR (2025-2032): 38.80%
Key Findings of Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market
- The Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at 12.33 USD Million in 2024.
- The Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market is likely to grow at a CAGR of 38.80% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Research & Academic Institutes in End User Segment accounted for the largest share of the market with a revenue of 11.06 USD Million
- The fastest growing segment Cancer Stem Cell Research in Application Segment grew Fastest with a CAGR of 47.39% during the forecast period from 2024 to 2032.
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation & Scope
Technology
- Immunocytochemical Technologies
- Negative Selection
- Single Spiral Microchannel
- Microchips
- Xenotransplantation Models
- Functional In vitro Cell Invasion Assay
- Molecular (RNA)-Based Technologies
- Ex Vivo Positive Selection
- CTC Enrichment Methods
- CTC Detection Methods
Application
- Multiple Chromosome Abnormalities
- Cancer Stem Cell Research
- Others
End User
- Physician Laboratories
- Hospitals
- Reference Laboratories
- Research & Academic Institutes
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 12.33 USD Million |
| Market Value in 2032 | 70.34 USD Million |
| CAGR (2025-2032) | 38.80% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Technology,Application,End User |
Regional Insights:
-
Leading Market (2024-2032): Australia, leading in terms of revenue 12.33 USD Million in 2024
- Key Country: Australia, leading in terms of revenue with value of 12.33 USD Million in 2024.
Segments and Scope
-
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By Technology
- CTC Detection Methods is the largest segment in Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 3.99 USD Million in the year 2024.
- CTC Detection Methods is the Fastest growing segment in Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 45.74 % in forecast period 2025-2032.
-
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By Application
- Cancer Stem Cell Research is the largest segment in Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 4.61 USD Million in the year 2024.
- Cancer Stem Cell Research is the Fastest growing segment in Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 47.39 % in forecast period 2025-2032.
-
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By End User
- Research & Academic Institutes is the largest segment in Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 11.06 USD Million in the year 2024.
- Research & Academic Institutes is the Fastest growing segment in Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 39.97 % in forecast period 2025-2032.
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| Natera, Inc. | |||
| Illumina, Inc. | |||
| Immucor | |||
| Thermo Fisher Scientific Inc. | |||
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Million
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Technology,Application,End User.
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 12.33(Revenue in USD Million) in 2020.
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 38.80% during the forecast period of 2024 to 2032.
The Research & Academic Institutes segment is expected to dominate the Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market, holding a largest market share of 11.06 USD Million in 2024
Coming Soon....
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation & Scope
Technology
- Immunocytochemical Technologies
- Negative Selection
- Single Spiral Microchannel
- Microchips
- Xenotransplantation Models
- Functional In vitro Cell Invasion Assay
- Molecular (RNA)-Based Technologies
- Ex Vivo Positive Selection
- CTC Enrichment Methods
- CTC Detection Methods
Application
- Multiple Chromosome Abnormalities
- Cancer Stem Cell Research
- Others
End User
- Physician Laboratories
- Hospitals
- Reference Laboratories
- Research & Academic Institutes
Frequently Asked Questions
The Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Technology,Application,End User.
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 12.33(Revenue in USD Million) in 2020.
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 38.80% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market for final year is USD 70.34 (USD Million).
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Technology,Application,End User.
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 12.33(Revenue in USD Million) in 2020.
Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 38.80% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market for final year is USD 70.34 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.